Stryker Corporation (SYK)
NYSE: SYK · Real-Time Price · USD
385.68
-3.00 (-0.77%)
At close: Nov 20, 2024, 4:00 PM
386.91
+1.23 (0.32%)
Pre-market: Nov 21, 2024, 5:32 AM EST
Stryker Revenue
Stryker had revenue of $5.49B in the quarter ending September 30, 2024, with 11.92% growth. This brings the company's revenue in the last twelve months to $21.97B, up 10.51% year-over-year. In the year 2023, Stryker had annual revenue of $20.50B with 11.11% growth.
Revenue (ttm)
$21.97B
Revenue Growth
+10.51%
P/S Ratio
6.68
Revenue / Employee
$822,996
Employees
26,700
Market Cap
147.03B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 20.50B | 2.05B | 11.11% |
Dec 31, 2022 | 18.45B | 1.34B | 7.84% |
Dec 31, 2021 | 17.11B | 2.76B | 19.21% |
Dec 31, 2020 | 14.35B | -533.00M | -3.58% |
Dec 31, 2019 | 14.88B | 1.28B | 9.43% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Pfizer | 59.38B |
Sanofi | 54.03B |
AstraZeneca | 51.21B |
Bristol-Myers Squibb Company | 47.44B |
Thermo Fisher | 42.37B |
Amgen | 32.53B |
Danaher | 23.74B |
Boston Scientific | 15.91B |
SYK News
- 1 day ago - Stryker Bringing in Big Money - FXEmpire
- 1 day ago - Stryker unveils Oculan Lighting Platform to enhance surgical visualization and illumination - PRNewsWire
- 6 days ago - Stryker launches next generation of SurgiCount+ to help improve the standard of care in hospitals for sponge management and blood loss assessment - PRNewsWire
- 22 days ago - Stryker Corporation (SYK) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Stryker: A High Quality MedTech Name Investors Should Own - Seeking Alpha
- 5 weeks ago - Stryker: More Earnings Growth And Higher Prices Ahead - Seeking Alpha
- 5 weeks ago - Stryker's Acquisition Spree: Double-Digit Growth on the Horizon - Benzinga
- 7 weeks ago - Stryker to announce its third quarter 2024 financial results - GlobeNewsWire